J Michael Kilby

10.6k total citations · 3 hit papers
53 papers, 6.5k citations indexed

About

J Michael Kilby is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, J Michael Kilby has authored 53 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Virology, 40 papers in Infectious Diseases and 18 papers in Epidemiology. Recurrent topics in J Michael Kilby's work include HIV Research and Treatment (45 papers), HIV/AIDS Research and Interventions (26 papers) and HIV/AIDS drug development and treatment (25 papers). J Michael Kilby is often cited by papers focused on HIV Research and Treatment (45 papers), HIV/AIDS Research and Interventions (26 papers) and HIV/AIDS drug development and treatment (25 papers). J Michael Kilby collaborates with scholars based in United States, China and Canada. J Michael Kilby's co-authors include Michael S. Saag, George M. Shaw, John C. Kappes, Julie M. Decker, Xiping Wei, Xiaoyun Wu, Martin A. Nowak, Hongmei Liu, Ramin B. Arani and Jesus F. Salazar-Gonzalez and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

J Michael Kilby

53 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody neutralization and escape by HIV-1

2003 1.8k citations Xiping Wei, Julie M. Decker et al. Nature profile →
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

2002 1.3k citations Xiping Wei, Julie M. Decker et al. profile →
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1998 819 citations J Michael Kilby, Michael S. Saag et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Michael Kilby United States	26	5.2k	3.7k	2.0k	1.4k	1.2k	53	6.5k
Yunzhen Cao United States	24	5.5k 1.1×	3.0k 0.8×	3.0k 1.5×	1.4k 1.0×	822 0.7×	33	6.6k
Cynthia A. Derdeyn United States	35	5.0k 1.0×	3.0k 0.8×	2.2k 1.1×	1.2k 0.9×	982 0.8×	85	5.7k
Terri Wrin United States	49	7.5k 1.4×	5.0k 1.4×	2.7k 1.4×	1.3k 0.9×	1.5k 1.2×	102	8.4k
Francine E. McCutchan United States	49	6.5k 1.3×	4.9k 1.3×	1.7k 0.9×	1.7k 1.2×	1.2k 1.0×	119	7.8k
Xiping Wei United States	13	7.3k 1.4×	3.9k 1.1×	3.5k 1.8×	1.7k 1.1×	1.5k 1.2×	23	8.4k
Jesus F. Salazar-Gonzalez United States	20	3.9k 0.7×	2.0k 0.5×	2.1k 1.1×	1.1k 0.8×	1.0k 0.8×	36	5.1k
Yaoxing Huang United States	38	4.9k 1.0×	4.2k 1.1×	4.2k 2.1×	1.3k 0.9×	1.9k 1.6×	84	9.1k
François Clavel France	43	6.2k 1.2×	4.9k 1.3×	1.3k 0.7×	1.6k 1.1×	1.5k 1.2×	84	7.6k
Françis Barin France	38	3.6k 0.7×	3.1k 0.8×	1.5k 0.8×	2.0k 1.4×	580 0.5×	210	5.9k
Anthony L. DeVico United States	37	5.2k 1.0×	2.4k 0.7×	3.9k 2.0×	1.3k 0.9×	1.4k 1.1×	105	7.2k

Countries citing papers authored by J Michael Kilby

Since Specialization

Citations

This map shows the geographic impact of J Michael Kilby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Michael Kilby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Michael Kilby more than expected).

Fields of papers citing papers by J Michael Kilby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Michael Kilby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Michael Kilby. The network helps show where J Michael Kilby may publish in the future.

Co-authorship network of co-authors of J Michael Kilby

This figure shows the co-authorship network connecting the top 25 collaborators of J Michael Kilby. A scholar is included among the top collaborators of J Michael Kilby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Michael Kilby. J Michael Kilby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Linda, et al.. (2017). Use of an Outreach Coordinator to Reengage and Retain Patients with HIV in Care. AIDS Patient Care and STDs. 31(5). 222–226. 17 indexed citations

Rolfe, Robert, Lisa L. Steed, Cassandra D. Salgado, & J Michael Kilby. (2016). Actinomyces meyeri, a Common Agent of Actinomycosis. The American Journal of the Medical Sciences. 352(1). 53–62. 14 indexed citations

Luo, Zhenwu, Лей Ма, Lumin Zhang, et al.. (2015). Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine. 34(16). 1945–1955. 12 indexed citations

Zhang, Lumin, Zhenwu Luo, Scott F. Sieg, et al.. (2014). Plasmacytoid Dendritic Cells Mediate Synergistic Effects of HIV and Lipopolysaccharide on CD27⁺IgD^–Memory B Cell Apoptosis. Journal of Virology. 88(19). 11430–11441. 13 indexed citations

Heath, Sonya L., Steffanie Sabbaj, Anju Bansal, J Michael Kilby, & Paul A. Goepfert. (2010). CD8 T-Cell Proliferative Capacity Is Compromised in Primary HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(3). 213–221. 9 indexed citations

Markowitz, Martin, Florin Vaida, C. Bradley Hare, et al.. (2010). The Virologic and Immunologic Effects of Cyclosporine as an Adjunct to Antiretroviral Therapy in Patients Treated during Acute and Early HIV‐1 Infection. The Journal of Infectious Diseases. 201(9). 1298–1302. 24 indexed citations

Kempf, Mirjam-Colette, et al.. (2009). Gender Differences in Discontinuation of Antiretroviral Treatment Regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(3). 336–341. 54 indexed citations

Hornberger, John, J Michael Kilby, Neil Wintfeld, & Jesse Green. (2006). Cost-Effectiveness of Enfuvirtide in HIV Therapy for Treatment-Experienced Patients in the United States. AIDS Research and Human Retroviruses. 22(3). 240–247. 16 indexed citations

Funkhouser, Ellen, et al.. (2006). Factors Associated with Delayed Initiation of HIV Medical Care Among Infected Persons Attending a Southern HIV/AIDS Clinic. Southern Medical Journal. 99(5). 472–481. 55 indexed citations

10.

Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2003). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 19(1). 83–83. 6 indexed citations

11.

Wei, Xiping, Julie M. Decker, Shuyi Wang, et al.. (2003). Antibody neutralization and escape by HIV-1. Nature. 422(6929). 307–312. 1842 indexed citations breakdown →

12.

Kilby, J Michael & Joseph J. Eron. (2003). Novel Therapies Based on Mechanisms of HIV-1 Cell Entry. New England Journal of Medicine. 348(22). 2228–2238. 190 indexed citations

13.

Lalezari, Jacob, Joseph J. Eron, Margrit Carlson, et al.. (2003). A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS. 17(5). 691–698. 113 indexed citations

14.

Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2002). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 18(10). 685–693. 152 indexed citations

15.

Chen, Ray Y., J Michael Kilby, & Michael S. Saag. (2002). Enfuvirtide. Expert Opinion on Investigational Drugs. 11(12). 1837–1843. 33 indexed citations

16.

Bucy, R. Pat & J Michael Kilby. (2001). Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics?. AIDS. 15. S36–S42. 20 indexed citations

17.

Hockett, Richard D., et al.. (2000). Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR. Journal of Virological Methods. 87(1-2). 1–12. 8 indexed citations

18.

Hoesley, Craig, et al.. (2000). Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside Reverse‐Transcriptase–Inhibitor Therapy in Clinical Practice. Clinical Infectious Diseases. 31(4). 1095–1097. 3 indexed citations

19.

Kilby, J Michael, et al.. (2000). Recurrence of the Acute HIV Syndrome after Interruption of Antiretroviral Therapy in a Patient with Chronic HIV Infection: A Case Report. Annals of Internal Medicine. 133(6). 435–438. 47 indexed citations

20.

Kilby, J Michael & Michael S. Saag. (1996). Clinical Experience with Non-Nucleoside Reverse Transcriptase Inhibitors: L-697,661 and Nevirapine. Advances in experimental medicine and biology. 394. 291–298. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact